Barnes Retina Institute
St Louis, Missouri, 63110, United States
NCT Number: NCT00406263
Progression of nuclear sclerotic cataract after pars plana vitrectomy has been recognized for many years The mechanism for the rapid progression of nuclear sclerotic cataract remains unclear. The objective of this trial is to evaluate and compare the level and progression of cataract advancement in controls versus eyes that have undergone 20-gauge pars plana vitrectomy and 25-gauge pars plana vitrectomy.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
St Louis, Missouri, 63110, United States
Approximately 105 patients will be recruited to obtain 35 control eyes that have not had pars plana vitrectomy and 35 eyes who will have undergone 20-gauge pars plana vitrectomy and 35 eyes will have undergone 25-gauge pars plana vitrectomy. Scheimpflug crystalline lens photographs will be taken for evaluation of level and progression of cataract development.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
scheimpflug photographs
Barnes Retina Institute
Other
Comparison of Scheimpflug Photos of the Crystalline Lens in Patients Who Have Undergone Vitrectony Surgery and Controls
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06264830
Cataract, Eye Diseases
Taipei, Taiwan
View Trial DetailsNCT07767643
Anxiety, Anxiety Disorders
Yatağan, Muğla, Turkey (Türkiye)
View Trial DetailsNCT07092020
Cataract, Cataract Senile
Sofia, Bulgaria
View Trial DetailsNCT06555770
Anxiety Disorders, Cataract
Samsun, Turkey (Türkiye)
View Trial Details